CanSino Biologics Inc (CASBF)
2.10
0.00 (0.00%)
USD |
OTCM |
May 02, 16:00
CanSino Biologics Debt to Equity Ratio: 0.412 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.412 |
| December 31, 2023 | 0.4665 |
| September 30, 2023 | 0.3116 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.3729 |
| March 31, 2023 | |
| December 31, 2022 | 0.3636 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3116
Minimum
Sep 2023
0.4665
Maximum
Dec 2023
0.3853
Average
0.3729
Median
Jun 2023
Debt to Equity Ratio Benchmarks
| Sinovac Biotech Ltd | 0.0292 |
| CASI Pharmaceuticals Inc | 0.7819 |
| Zai Lab Ltd | 0.00 |
| I-MAB | 0.0517 |
| Gracell Biotechnologies Inc (DELISTED) | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.204B |
| Total Liabilities (Quarterly) | 486.51M |
| Shareholders Equity (Quarterly) | 717.58M |
| Current Ratio | 2.389 |
| Net Debt Paydown Yield | 2.61% |